Citation

Daniel J. Skiest, M.D., F.A.C.P., Amy Krambrink, M.S., Zhaohui Su, Ph.D., Kevin R. Robertson, Ph.D., David M. Margolis, M.D. Improved measures of quality of life, lipid profile and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170. Journal of Acquired Immune Deficiency Syndromes. 2008 Dec 01; 49(4):377-83. PMCID: PMC2634828.

Citation

Lisa M. Demeter, M.D., Lisa Mukherjee, M.S., Robin DiFrancesco, M.T., (ASCP), M.B.A., Hongyu Jiang, Ph.D., Robert DiCenzo, Pharm.D., Barbara Bastow, R.N., B.S.N., Alex R. Rinehart, Ph.D., Gene D. Morse, Pharm.D., Mary Albrecht, M.D. The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients. HIV Clinical Trials. 2008 Jan 01; 9(1):61-72. PMCID: PMC2821072.

Citation

James H. Stein, M.D., Lauren Komarow, M.S., Bruno R. Cotter, M.D., Judith Silverstein Currier, M.D., M.Sc., Michael P. Dube, M.D., Carl J. Fichtenbaum, M.D., Mariana Gerschenson, Ph.D., Carol K. Mitchell, Robert L. Murphy, M.D., Kathleen E. Squires, M.D., Robert A. Parker, Sc.D., Francesca J. Torriani, M.D. Lipoprotein changes in HIV-infected antiretroviral-naive individuals after starting antiretroviral therapy: ACTG study A5152s. Journal of Clinical Lipidology. 2008 Dec 01; 2(6):464-71. PMID: 19956354; PMCID: PMC2636959.

Citation

Susan C. Morpeth, MB ChB, DTM&H, Nathan Thielman, M.D., M.P.H., Habib O. Ramadhani, M.D., John David Hamilton, M.D., Jan Ostermann, Ph.D., Peter R. Kisenge, M.D., MMED, Humphrey J. Shao, M.D., L.Barth Reller, M.D., DTM&H, Dafrosa K. Itemba, B.A., Noel E. Sam, John Alexander Bartlett, M.D., John F. Shao, M.D., Ph.D., John A. Crump, MB ChB, DTM&H. Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania. Journal of Acquired Immune Deficiency Syndromes. 2008 Apr 15; 47(5):585-91. PMCID: PMC2586846.

Citation

Nicholas T. Funderburg, Ph.D., Angel A. Luciano, Wei Jiang, M.D., M.S., Benigno Rodriguez, M.D., Scott F. Sieg, Ph.D., Michael M. Lederman, M.D. Toll-like receptor ligans induce human T cell activation and death, a model for HIV pathogenesis. Public Library of Science One. 2008 Apr 01; 3(4):1-7. PMCID: PMC2271052.

Citation

Nancy C. Connolly, M.D., M.P.H., Theresa Whiteside, Ph.D., Cara C. Wilson, M.D., Venkatswarlu Kondragunta, Charles Rinaldo, Jr., Ph.D., Sharon A. Riddler, M.D., M.P.H. Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals. Clinical and Vaccine Immunology. 2008 Feb 01; 15(2):284-92. PMCID: PMC2238066.

Citation

Susan J. Little, M.D., Simon D. W. Frost, D.Phil., Joseph K. Wong, M.D., Davey M. Smith, M.D., Sergei L. Kosakovsky Pond, Ph.D., Caroline Ignacio, Neil Parkin, Christos J. Petropoulos, Ph.D., Douglas D. Richman, M.D. Persistence of transmitted drug resistance among subjects with primary HIV infection. Journal of Virology. 2008 Jun 01; 82(11):5510-18. PMCID: PMC2395184.

Citation

Sergei L. Kosakovsky Pond, Ph.D., Art Poon, Selene Zarate, Davey M. Smith, M.D., Susan J. Little, M.D., Satish K. Pillai, Ronald J. Ellis, M.D.,Ph.D., Joseph K. Wong, M.D., Andrew Leigh-Brown, Ph.D., Douglas D. Richman, M.D., Simon D. W. Frost, D.Phil. Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Statistics In Medicine. 2008 Oct 15; 27(23):4779-89. PMCID: PMC2634745.